Single Dose Pharmacokinetic Comparison of Citrulline Dietary Supplements

This study demonstrates that a 2 g dose of citrulline HCl provides a faster and more efficient method for increasing plasma arginine levels compared to a 6 g dose of L-citrulline, due to improved conversion rates and reduced urinary excretion.

The Gist

The Big Idea: The "Arginine Factory" Problem

Imagine your body is a bustling city. One of the most important workers in this city is a molecule called Arginine. Arginine is like a "traffic controller" for your blood vessels; it helps them relax and open up, allowing blood (and oxygen) to flow freely to your muscles and heart. This is great for exercise and heart health.

However, there's a problem: Arginine is a picky worker.
If you try to eat Arginine directly (like taking a pill), your liver acts like a strict security guard at the city gate. It catches most of the Arginine before it can even get into the bloodstream, breaking it down or sending it away. This is called "first-pass metabolism." It's like trying to mail a letter, but the post office throws away 80% of them before they leave the building.

The Solution: The "Citrulline" Trojan Horse

To get around the security guard, scientists use a clever trick. They send in a different molecule called Citrulline.

• Citrulline is like a "Trojan Horse." It is invisible to the liver's security guard. It slips right through the gate, enters the bloodstream, and travels to the kidneys.
• Once inside the kidneys, the body has a special factory that converts Citrulline into Arginine. Now, the Arginine is created inside the city, bypassing the security guard entirely.

The Experiment: Testing Different "Trojan Horses"

For years, people have used L-Citrulline (the standard version) to do this. But the researchers in this paper wondered: Can we make the Trojan Horse even better?

They tested a new, improved version called Citrulline HCl. Think of L-Citrulline as a heavy, bulky brick, and Citrulline HCl as a lightweight, soluble sponge. The "sponge" dissolves faster in water and might move through the body more efficiently.

They set up a race with three groups of healthy people:

1. Group A: Took a standard 6g dose of the old "brick" (L-Citrulline).
2. Group B: Took a 6g dose of the new "sponge" (Citrulline HCl).
3. Group C: Took a tiny 2g dose of the new "sponge" (Citrulline HCl).

The Results: Speed and Efficiency

Here is what happened when they measured the blood:

1. The "Brick" Group (6g L-Citrulline):

• The Ride: It took a while to get moving. It took 120 minutes (2 hours) to reach the peak amount of Arginine in the blood.
• The Waste: A lot of the "brick" didn't get converted. Instead, it just passed through the kidneys and ended up in the urine. It was like throwing away 45% of your effort.

2. The "Big Sponge" Group (6g Citrulline HCl):

• The Ride: Even though they took the same amount (6g), the new sponge didn't actually raise the Citrulline levels as high as the brick did.
• The Magic: However, it turned into Arginine just as well as the brick did. It was more efficient. Less was wasted in the urine.

3. The "Tiny Sponge" Group (2g Citrulline HCl):

• The Ride: This was the surprise winner. Even though they took one-third of the dose (2g vs 6g), the results were incredible.
• Speed: It reached peak Arginine levels in just 60 minutes (half the time of the others!).
• Efficiency: It was the most efficient converter. For every gram of this supplement, the body produced 2.2 times more Arginine than it did with the standard L-Citrulline.
• The Waste: Very little was wasted in the urine. Almost all of it was turned into the useful Arginine the body needed.

The Analogy: The Pizza Delivery

Imagine you want to get a hot pizza (Arginine) to your house (your muscles).

• L-Citrulline (The Brick): You order a huge pizza (6g). The delivery driver (the liver) eats half of it before it gets to the door. The rest arrives, but it takes 2 hours to get there because the driver is slow.
• Citrulline HCl (The Sponge): You order a pizza wrapped in a special, heat-retaining box.
  • The 6g Box: The driver still eats a little bit, but the box keeps the pizza hot. It arrives in 2 hours, just as good as the first one, but with less waste.
  • The 2g Box: You order a small, super-efficient pizza in a high-tech box. The driver doesn't eat any of it. It zooms to your house in 1 hour. Even though the pizza was smaller, you got more "hot pizza" per dollar spent than with the huge, slow pizza.

The Bottom Line

The study concludes that Citrulline HCl is a superior supplement compared to the standard L-Citrulline.

• It works faster: You get the benefits (better blood flow) in half the time.
• It works better: Your body converts it into the useful stuff (Arginine) much more efficiently.
• You need less: You can take a smaller dose (2g) and get better results than taking a huge dose (6g) of the old stuff.

In simple terms: If you are taking Citrulline for exercise or heart health, the new "HCl" version is like upgrading from a slow, leaky bucket to a high-pressure fire hose. You get more water (Arginine) to the fire (your muscles) in less time, with less waste.

Technical Summary

1. Problem Statement

Citrulline is a non-essential amino acid widely used as a dietary supplement to improve cardiovascular health and exercise performance by increasing systemic arginine levels. Unlike oral arginine, which suffers from significant first-pass metabolism in the liver and poor intestinal permeability, citrulline is readily absorbed and converted to arginine primarily in the kidneys (the intestinal-renal axis).

While L-citrulline is the standard formulation, the study addresses the potential for improved delivery using alternative salt forms, specifically Citrulline HCl. Citrulline HCl possesses superior aqueous solubility compared to L-citrulline. The central research question is whether this improved solubility translates to enhanced pharmacokinetics, specifically:

• Faster absorption and conversion to arginine.
• Higher relative bioavailability of arginine.
• Reduced urinary waste (excretion) of unconverted citrulline.

2. Methodology

Study Design:

• Type: Single-dose, randomized, open-label pharmacokinetic study.
• Subjects: 17 healthy adult volunteers (after excluding 6 subjects with creatinine clearance <60 ml/min from an initial 23).
• Groups: Subjects were randomly assigned to one of three treatment arms:
  1. L-citrulline: 6 g dose (Standard).
  2. Citrulline HCl: 6 g dose.
  3. Citrulline HCl: 2 g dose.
• Administration: Supplements were dissolved in 125 mL of water and administered after a 3-hour fast.
• Sampling:
  • Plasma: Collected at baseline and at 30, 60, 90, 120, 150, and 180 minutes post-dose.
  • Urine: 24-hour collection prior to and immediately following supplementation.
• Analytical Methods:
  • Technique: Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry (LC-MRM/MS) using an Agilent 1290 UHPLC and 6495B triple-quadrupole MS.
  • Targets: Quantification of Citrulline, Arginine, and Creatinine.
• Pharmacokinetic (PK) Parameters:
  • $C_{max}$ (Maximum concentration), $T_{max}$ (Time to peak), and $AUC_{0-\infty}$ (Area Under the Curve).
  • Conversion Efficiency: Calculated as the ratio of Plasma Arginine $AUC$ to Plasma Citrulline $AUC$.
  • Renal Clearance: Calculated using 24-hour urine volumes and plasma concentrations to determine fractional reabsorption rates.
• Statistical Analysis: One-way ANOVA followed by Fisher's LSD test.

3. Key Contributions

• Novel Formulation Comparison: This is one of the first studies to directly compare the PK profiles of L-citrulline against Citrulline HCl in human subjects, specifically evaluating different dosage strengths (6g vs. 2g) of the HCl salt.
• Mechanistic Insight: The study provides evidence that the improved performance of Citrulline HCl is not due to increased absorption (as renal clearance was similar across groups) but rather due to a more efficient metabolic conversion of citrulline to arginine in the kidney.
• Dose Optimization: The study challenges the assumption that "more is better," demonstrating that a significantly lower dose (2g) of Citrulline HCl outperforms the standard 6g L-citrulline dose in terms of arginine bioavailability and speed of onset.

4. Key Results

A. Plasma Citrulline Kinetics:

• L-citrulline (6g): Produced the highest $C_{max}$ (1421 µM) and $AUC$ (155,724 µM*min).
• Citrulline HCl (6g): Resulted in significantly lower plasma citrulline levels ($C_{max}$ 790 µM; $AUC$ 96,861 µM*min) compared to L-citrulline.
• Citrulline HCl (2g): Showed the lowest plasma citrulline exposure ($C_{max}$ 277 µM).

B. Plasma Arginine Kinetics (The Critical Finding):

• Despite lower plasma citrulline levels, the 6g Citrulline HCl group achieved arginine levels comparable to the 6g L-citrulline group ($C_{max}$ ~113 µM vs 128 µM).
• The 2g Citrulline HCl group reached peak arginine levels significantly faster ($T_{max}$ = 60 mins) compared to both 6g groups ($T_{max}$ = 120 mins).
• Relative Bioavailability:
  • 6g Citrulline HCl: 125% relative arginine bioavailability compared to L-citrulline.
  • 2g Citrulline HCl: 226% relative arginine bioavailability compared to L-citrulline.

C. Conversion Efficiency & Urinary Excretion:

• Conversion Ratio (Arginine/Citrulline AUC):
  • L-citrulline: ~0.23 (Least efficient).
  • 6g Citrulline HCl: 0.37 (50% improvement).
  • 2g Citrulline HCl: ~0.67 (2.8-fold improvement over L-citrulline).
• Urinary Excretion:
  • L-citrulline caused a massive 45-fold increase in urinary citrulline excretion.
  • 6g Citrulline HCl: Only a 15-fold increase.
  • 2g Citrulline HCl: Only a 7-fold increase.
  • Interpretation: The reduced urinary excretion of citrulline with HCl formulations indicates that less citrulline is being wasted and more is being successfully converted to arginine.

5. Significance and Conclusion

The study concludes that Citrulline HCl is a superior formulation to standard L-citrulline for increasing systemic arginine levels.

• Mechanism: The improved performance is attributed to a more efficient conversion rate of citrulline to arginine within the kidney, likely facilitated by the improved solubility and bioavailability of the HCl salt, rather than changes in renal clearance or intestinal absorption rates.
• Clinical/Practical Implication:
  • Efficiency: A 2g dose of Citrulline HCl provides a faster onset of action (60 mins vs 120 mins) and a higher total arginine yield than a standard 6g dose of L-citrulline.
  • Dosing Strategy: The data suggests that splitting daily doses into smaller, more frequent administrations of Citrulline HCl could optimize arginine delivery for cardiovascular support and muscle performance, avoiding the saturation of conversion pathways observed with high single doses of L-citrulline.
• Safety: No adverse events were reported, and the reduced urinary excretion suggests a lower metabolic burden regarding waste elimination.

Note: As this is a preprint (medRxiv), the findings have not yet undergone peer review, though the study design and analytical methods appear rigorous.